3rd Quarter - Report

WILLIAMS AND JENSEN, PLLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about policies impacting pharmaceutical development, approval, and reimbursement; 21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine. S. 2030 Advancing Targeted Therapies for Rare Diseases Act of 2015.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2030 (114th), H.R. 6 (114th)

Medicare/Medicaid MMM

General education about policies impacting pharmaceutical development, approval, and reimbursement; 21st Century Cures Initiative H.R. 6 (House Energy and Commerce Committee)and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Medical/Disease Research/Clinical Labs MED

21st Century Cures Initiative H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine. S. 2030 Advancing Targeted Therapies for Rare Diseases Act of 2015.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), S. 2030 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.